Figure 3.
(a) Individual 24-hour urine protein-to-creatinine ratio and (b) estimated glomerular filtration rate in the first-line calcineurin inhibitor (CNI) group. Continuous lines represent patients who responded to therapy; dotted lines, patients with resistant disease; dashed lines, patients with initial response followed by relapse; stars, patients who progressed to end-stage renal disease.